10:27 AM EDT, 05/27/2026 (MT Newswires) -- Abbott (ABT) said Wednesday it has secured the CE Mark for its dual glucose-ketone sensing technology for people with diabetes.

The systems, branded as Libre Duo and Libre Duo 10 Day, are designed to continuously measure glucose and ketone levels every minute, the company said.

Abbott said it plans to start launching Libre Duo systems in some European countries later this year.

Price: 86.44, Change: -0.23, Percent Change: -0.27